These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 19447821

  • 1. Relationship of CD4+ T-cell counts and plasma HIV-1 RNA levels with serological HBeAg/anti-HBe patterns obtained in West-African HBV-HIV-1-co-infected children.
    Rouet F, Chaix ML, Kpozehouen A, Inwoley A, Anaky MF, Fassinou P, Rouzioux C, Blanche S, Msellati P.
    J Trop Pediatr; 2009 Dec; 55(6):409-12. PubMed ID: 19447821
    [Abstract] [Full Text] [Related]

  • 2. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
    Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe P, Leroy V, Dabis F, Rouzioux C, ANRS 1236 DITRAME-B&C Study Group.
    J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN, Rumi MA, Hasanat MA, Azam MG, Ahmed S, Salam MA, Islam LN, Hassan MS.
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [Abstract] [Full Text] [Related]

  • 5. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 6. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
    Han Y, Tang Q, Zhu W, Zhang X, You L.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
    [Abstract] [Full Text] [Related]

  • 7. [Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells].
    Smit MC, Haverkamp MH, Weersink AJ, Boucher CA, Hoepelman IM.
    Ned Tijdschr Geneeskd; 2004 Nov 20; 148(47):2330-4. PubMed ID: 15587052
    [Abstract] [Full Text] [Related]

  • 8. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI.
    J Med Virol; 2009 Mar 20; 81(3):441-5. PubMed ID: 19152397
    [Abstract] [Full Text] [Related]

  • 9. Serum hepatitis B virus DNA: relationship with the e-antigen and anti-e status in chronic carriers.
    Yap SF, Wong NW, Goh KL.
    Malays J Pathol; 1994 Jun 20; 16(1):57-62. PubMed ID: 16329577
    [Abstract] [Full Text] [Related]

  • 10. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.
    Landrum ML, Roediger MP, Fieberg AM, Weintrob AC, Okulicz JF, Crum-Cianflone NF, Ganesan A, Lalani T, Macalino GE, Chun HM.
    J Med Virol; 2011 Sep 20; 83(9):1537-43. PubMed ID: 21739443
    [Abstract] [Full Text] [Related]

  • 11. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
    Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM.
    J Clin Virol; 2006 Jan 20; 35(1):14-20. PubMed ID: 15916918
    [Abstract] [Full Text] [Related]

  • 12. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
    Lu H, Ma LX, Xu WS, Zhang HY, Yu LJ, Duan HY.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar 20; 11(3):173-5. PubMed ID: 12681068
    [Abstract] [Full Text] [Related]

  • 13. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection.
    Bozdayi G, Türkyilmaz AR, Idilman R, Karatayli E, Rota S, Yurdaydin C, Bozdayi AM.
    J Med Virol; 2005 Aug 20; 76(4):476-81. PubMed ID: 15977237
    [Abstract] [Full Text] [Related]

  • 14. [Analysis of the correlation between PreS1-Ag, PreS2-Ag, HBeAg and HBV DNA in the serum of chronic hepatitis B patients].
    Dou YL, Han JH, Li YZ, DI Q, Ni AP.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 24; 87(28):1984-6. PubMed ID: 17923040
    [Abstract] [Full Text] [Related]

  • 15. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, Hung CC, Chen MY, Chang SC.
    Clin Infect Dis; 2007 Nov 01; 45(9):1221-9. PubMed ID: 17918088
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter?
    Thakur V, Guptan RC, Malhotra V, Basir SF, Sarin SK.
    J Assoc Physicians India; 2002 Nov 01; 50():1386-94. PubMed ID: 12583467
    [Abstract] [Full Text] [Related]

  • 17. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
    Kim KH, Na IH, Cha JM, Cho YK, Park SY, Kim HP, Song CS, Heo J, Cho M.
    Taehan Kan Hakhoe Chi; 2003 Dec 01; 9(4):284-92. PubMed ID: 14695695
    [Abstract] [Full Text] [Related]

  • 18. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.
    Am J Gastroenterol; 2005 Nov 01; 100(11):2463-71. PubMed ID: 16279901
    [Abstract] [Full Text] [Related]

  • 19. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
    Filippini P, Coppola N, Pisapia R, Scolastico C, Marrocco C, Zaccariello A, Nacca C, Sagnelli C, De Stefano G, Ferraro T, De Stefano C, Sagnelli E.
    AIDS; 2006 Jun 12; 20(9):1253-60. PubMed ID: 16816553
    [Abstract] [Full Text] [Related]

  • 20. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB, Naoumov NV, Gilson RJ, Tedder RS.
    J Clin Virol; 2007 Jul 12; 39(3):199-204. PubMed ID: 17526429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.